Influenza Diagnostic Global Market Report 2022 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological Assays, Others), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : January 2022 | SKU CODE : 7561 | Delivery Time: 2-3 business days | Format :


The influenza diagnostic market consists of sales of diagnostic tests used to diagnose influenza including viral culture, serology, rapid antigen testing, Reverse Transcription-Polymerase Chain Reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting the diagnostics tests for influenza virus detection.

The main traditional diagnostic test types of influenza diagnostics are Rapid Influenza Diagnostic Tests (RIDT), viral culture, DFA, serological assays and others. Rapid influenza diagnostic tests (RIDTs) are immunoassays that can detect the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and provide a qualitative result (positive vs. negative). The various molecular diagnostic tests include Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests and are used by hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users.

The global influenza diagnostic market size is expected to grow from $1.75 billion in 2021 to $1.89 billion in 2022 at a compound annual growth rate (CAGR) of 8.4%. The change in the influenza diagnostic market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The influenza diagnostic market is expected to reach $2.53 billion in 2026 at a CAGR of 7.6%.

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations. Therefore, it is important to accelerate the pace of scientific research progress that can have the greatest public health impact. Many public and private health organizations, researchers, health professionals, biopharmaceutical companies have maximized the spending for research funds or grants to reduce the risk of the emergence of pandemic influenza. For instance, in 2019, the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, a new network of research centers that will work together to develop influenza vaccines. NIAID will provide up to approximately $51 million in total first-year funding for the program, which is designed to support the CIVICs program centers over seven years.

The variability in sensitivity and specificity among the influenza diagnostic tests is restraining the growth of the market. In most rapid flu tests, there are difficulties in identifying patients with influenza. The sensitivity of rapid flu tests ranges from 10-80% across various patient populations. Most diagnostic tests show an increase in the rate of false-negative results during low influenza virus activity, which often leads to an incorrect diagnosis. Thus, the variability in sensitivity and specificity is restraining the growth of the influenza diagnostic market.

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

In June 2019, Meridian Bioscience Inc., an international producer and distributor of a range of diagnostic test kits, completed its acquisition of GenePoc Inc., a Canadian provider of molecular diagnostic instruments and assays. Meridian will now include GenePOC’s state-of-the-art revogene molecular diagnostics platform, which offers samples to result in testing for single tests, as well as flexible multiplexing capability. GenePOC is a subsidiary of Debiopharm Group. It specializes in the development and commercialization of rapid molecular assays usable on the unique revogene platform for near-patient infectious disease diagnostic.

Major players in the influenza diagnostics market are F. Hoffmann-La Roche Ltd, Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience Inc. and GenMark Diagnostics.

The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the influenza diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global influenza diagnostic market is segmented -

1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others

2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Others

3) By End User: Hospitals and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others

    Table Of Contents

    1. Executive Summary

    2. Influenza Diagnostics Market Characteristics

    3. Influenza Diagnostics Market Trends And Strategies

    4. Impact Of COVID-19 On Influenza Diagnostics

    5. Influenza Diagnostics Market Size And Growth

    5.1. Global Influenza Diagnostics Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Influenza Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Influenza Diagnostics Market Segmentation

    6.1. Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Rapid influenza diagnostic tests (RIDT)

    Viral Culture

    DFA

    Serological assays

    Othes

    6.2. Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    Isothermal Nucleic Acid Amplification Tests (INAAT)

    Loop Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Other Isothermal Nucleic Acid Amplification Tests

    Other Molecular Diagnostic Tests

    6.3. Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospitals & Clinical Laboratories

    Diagnostic Reference Laboratories

    Academic/Research Institutes

    Other End Users

    7. Influenza Diagnostics Market Regional And Country Analysis

    7.1. Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Influenza Diagnostics Market

    8.1. Asia-Pacific Influenza Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Influenza Diagnostics Market

    9.1. China Influenza Diagnostics Market Overview

    9.2. China Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Influenza Diagnostics Market

    10.1. India Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Influenza Diagnostics Market

    11.1. Japan Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Influenza Diagnostics Market

    12.1. Australia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Influenza Diagnostics Market

    13.1. Indonesia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Influenza Diagnostics Market

    14.1. South Korea Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Influenza Diagnostics Market

    15.1. Western Europe Influenza Diagnostics Market Overview

    15.2. Western Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Influenza Diagnostics Market

    16.1. UK Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Influenza Diagnostics Market

    17.1. Germany Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Influenza Diagnostics Market

    18.4. France Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Influenza Diagnostics Market

    19.1. Eastern Europe Influenza Diagnostics Market Overview

    19.2. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Influenza Diagnostics Market

    20.1. Russia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Influenza Diagnostics Market

    21.1. North America Influenza Diagnostics Market Overview

    21.2. North America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Influenza Diagnostics Market

    22.1. USA Influenza Diagnostics Market Overview

    22.2. USA Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Influenza Diagnostics Market

    23.1. South America Influenza Diagnostics Market Overview

    23.2. South America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Influenza Diagnostics Market

    24.1. Brazil Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Influenza Diagnostics Market

    25.1. Middle East Influenza Diagnostics Market Overview

    25.2. Middle East Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Influenza Diagnostics Market

    26.1. Africa Influenza Diagnostics Market Overview

    26.2. Africa Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Influenza Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Influenza Diagnostics Market Competitive Landscape

    27.2. Influenza Diagnostics Market Company Profiles

    27.2.1. F. Hoffmann-La Roche Ltd

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Quidel Corporation

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. ?h?rm? F??h?r

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Abbott Laboratories

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Hologic

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Influenza Diagnostics Market

    29. Influenza Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 47: Quidel Corporation Financial Performance
  • Table 48: ?h?rm? F??h?r Financial Performance
  • Table 49: Abbott Laboratories Financial Performance
  • Table 50: Hologic Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 47: Quidel Corporation Financial Performance
  • Figure 48: ?h?rm? F??h?r Financial Performance
  • Figure 49: Abbott Laboratories Financial Performance
  • Figure 50: Hologic Financial Performance
Global Multiplex Assays Market Overview And Prospects
Global Consumer Healthcare Market Size, Forecasts, And Opportunities
Global Negative Pressure Wound Therapy Market Overview And Prospects
Global Biobank Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Podiatry Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Telemedicine Services Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Telemedicine Technologies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Medication Adherence Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Robotic Surgery Services Global Market Report 2022 – By Component (Systems, Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery), By End-User (Hospitals, Ambulatory Surgery Centers (ASCs)) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Telemedicine Services Global Market Report 2022 – By Technology Outlook (Store and Foreward, Real time), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatalogy, Telecardiology), By Type (Web-based, Cloud-based, On-premises) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Fertility Services Market 2022 - By Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization (IVF), Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Fertility Services Global Market Report 2022 – By Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Revenue Cycle Management Software Global Market Report 2022 – By Product (Integrated, Standalone), By Function (Claim And Denial, Medical Biling And Coding, Patient Insurance Eligibility Check, Payment Remittance, Electronic Health Record (EHR), Clinical Documentation Improvement (CDI), Others), By Deployment (Web based, On premise, Cloud based) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Payer Services Global Market Report 2022– By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycle Management, Healthcare Reimbursement, Medical Billing Outsourcing), By End User (Public Payers, Private Payers) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Medical Billing Outsourcing Global Market Report 2022 – By Service (Front End, Back End), By End User (Hospitals, Physician Offices), By Component (In-house, Outsourced) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)